logo-loader
NASDAQ:TPIV

TapImmune Inc

Receive alerts
Market:
NASDAQ
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

TapImmunes vision is to be the leader in Immunotherapy by stimulating the body's own immune system to fight cancer and viral diseases.
 
Our strategy is to develop the most comprehensive approach in immunotherapy that stimulates T-killer and T-helper cells and to restore antigen presentation through a combination of our own technologies, licensing agreements and collaborations.